Generic Pharmaceutical Business Investment Opportunities in Maharashtra

The business operates in the pharmaceutical and medical devices export industry, focusing on therapies such as anaemia management, nephrology, and gynaecology. - With a current staff of 6 permanent employees, the business has made significant strides in increasing its client base, growing from 2 clients in the last fiscal year to 15 clients in the current fiscal year. - The company has outlined a road-map to achieve a turnover of 100 crore in the next 2 fiscal years, indicating a strong growth trajectory. - Initially starting as a short-term trading model, the business is now transitioning towards brand building and is in the process of registering its brand in 4 countries, showcasing a strategic shift in its business model. - The product portfolio comprises 80% medicines and 20% medical devices, with a focus on exporting these products to countries such as Zambia, Uganda, and Kenya. - The business sources medicines and equipment from India and exports them to international markets, highlighting its role in facilitating the global distribution of pharmaceutical and medical devices. - With a valid GST certificate for operations, the business is compliant with regulatory requirements, adding a layer of credibility to its operations.

Pharma manufacturing company, located in Nashik. - The plant is in its final stage of commissioning and will focus on the production of small volume parenterals in ampules, vials, PFS, and lyophilized products. - Technical inspection is pending, post which the business can obtain drug manufacturing license to start the manufacturing process. - Will be manufactured on a principle-to-principle and loan license basis for both local and export markets. - The product line includes human injectable products falling under drug categories such as antibiotics, steroids, analgesics etc. - Business model involves manufacturing products under the brand and formulation of other major pharmaceutical companies and supplying them for marketing and distribution. - The business is registered with the Ministry of Corporate Affairs (MCA), holds a Permanent Account Number (PAN), and is registered with the Micro, Small, and Medium Enterprises (MSME).

Our business is essentially a pharmaceutical marketing company that sells a broad range of medicines from multiple brands to its clients. - We have about 60 clients who are essentially pharmaceutical companies and international distributors in the East African countries like Kenya, Burundi, Malawi, etc. These clients provide us with recurring purchase orders. - The entire revenue of the company is generated through the export of these medicines to our clients. There are no domestic clients. However, we will soon commence undertaking clients in India as well. - Currently, we are dealing in 39 different brand names such as Cipla, Glenmark, etc. The products are supplied on the basis of purchase orders received. Logistics support is outsourced. This line of operations contributing to 100 percent of the company's revenue. - We are now seeking to expand our operations and start our own pharmaceutical brand name & manufacturing unit. The majority of the proceeds from this investment will be used to start the manufacturing unit. - The prospective investor will receive a 50 percent ownership of the entire registered business entity which includes pharma marketing, third-party medicine manufacturing, and generic pharmaceutical brand name lines of operations. These three will simple be different domains services under one company. - Our business is extremely valuable due to the owner's long standing relationships in the industry and enormous growth potential in the future. The valuation is based on our own estimate. - The business is registered in Raigarh, Maharashtra. However, we run operations from Navi Mumbai, Maharashtra. - Our business is entirely debt-free with no outstanding business loans, overdue, or defaults. - The company has two directors. One of them has a 75 percent ownership of the business. The other owns the remaining 25 percent of the business. There are no outside investors or shareholders.

Developing skincare products such as creams, powder and lotions. - We get the products manufactured by 6 manufacturers. - Products are sold under our brand name. - Currently have 27 products in our portfolio and we are working on developing 2 more products. - All our products have trademarks. - We sell our products to 21 stockists in Mumbai who further sell it to various hospitals and pharmacies. - We also promote our products to dermatologists, who then recommend our products to hospitals and patients. - Physical assets include inventory and office setup.

2012 established company into development and manufacturing of pharmaceutical products. - Regulatory and QMS consultants. - We either sell the full technology or manufacture and sell the final products. - We have developed more than 100+ products. 30 of which are blockbusters for which we have kept the manufacturing and supply rights. - From our manufacturing unit we manufacture about 60 lakh tablets daily. - The manufacturing set up has EU, TGA, Canadian accreditation. - We have our client base in UK, EU, US, Australia, Canada & South Africa. - We have out licensed a number of technologies to big pharma and large distributors across the globe and have 5 years commercial supplies rights for number of good volumes generic products. - Backed up with our own API where the molecules are niche. - Promoter is an IIT Delhi alumni having industry experience of more than two decade. Excellent team on development, Quality and Regulatory affairs. -Consultancy service provider to 50+ manufacturing sites across the globe.

2015 established company into manufacturing of pharmaceutical products. - We developed a progressive hospital-ICU based critical antibiotics available in major hospital brands in Category-A towns and metros. - We get the products manufactured from third parties and sell it under our brand name. - We have 15 manufacturers in India and abroad. We conduct a strict background check of the manufacturers. They need to fulfil 14 parameters which includes having WHO GMP certificate and a standard certificate of analysis. - In market we have released 8 products till now. Have 12 SKUs. - We have 45 distributors who distribute our products to hospitals and pharmacies. - We have a team of experienced executives who promote our products among professionals and hospitals. - Recipient of a pharma award by a well known name in the category - "excellence in marketing" - Promoter has an industry experience of 23 years in sales, marketing and consulting.

Traders of generic medicines. - Have tie ups with 2 manufacturing units. - We will be supplying it to the retail stores. - The revenue generation will start in 6 - 9 months. - Generate leads through own sales team. - Promoter has 15 years of industry experience.

A pharmaceutical and healthcare products business, based in Mumbai. - We get the medicines and healthcare products manufactured by third-party manufacturers. - We export our products to 5 countries and have a total of 20 clients. - Business has 1 pharmacy in Kenya. - Promoter has M. Pharm with management qualification in International Business & 20+ years experience in Pharma industry with 35 countries international marketing experience.